Loading...
•
Mar 31, 2020
Evolent Health Q1 2020 Earnings Report
Evolent Health's Q1 2020 financial performance was announced, demonstrating revenue growth and strategic advancements.
Key Takeaways
Evolent Health reported a 25.0% increase in GAAP revenue, reaching $247.3 million, and an Adjusted EBITDA of $3.6 million. The company added two new health plan partners and focused on supporting existing partners during the COVID-19 crisis.
GAAP revenue increased by 25.0% to $247.3 million.
Adjusted EBITDA was reported at $3.6 million.
Approximately 3.4 million lives were on the platform.
Two new health plan partners were added, utilizing New Century Health's services.
Forward Guidance
For the three months ended June 30, 2020, Adjusted Revenue is expected to be in the range of approximately $236.0 million to $247.0 million. Adjusted EBITDA is expected to be in the range of approximately $5.0million to $8.0 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...